Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WDR35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLTF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZZZ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GXYLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNL4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929500 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on